Edgestream Partners, L.P. Neogenomics Inc Transaction History

Edgestream Partners, L.P.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$13.4 - $17.73 $1.27 Million - $1.68 Million	-94,791 Reduced 73.15%	34,798 $513,000
Q2 2024 Aug 09, 2024	BUY	$13.01 - $15.77 $118,820 - $144,027	9,133 Added 7.58%	129,589 $1.8 Million
Q1 2024 May 10, 2024	BUY	$14.06 - $16.79 $1.69 Million - $2.02 Million	120,456 New	120,456 $1.89 Million
Q3 2023 Nov 14, 2023	BUY	$12.15 - $17.85 $405,554 - $595,815	33,379 Added 53.25%	96,062 $1.18 Million
Q2 2023 Aug 10, 2023	BUY	$14.1 - $19.83 $382,011 - $537,254	27,093 Added 76.13%	62,683 $1.01 Million
Q1 2023 May 15, 2023	SELL	$9.09 - $19.45 $154,575 - $330,747	-17,005 Reduced 32.33%	35,590 $619,000
Q4 2022 Feb 13, 2023	SELL	$6.45 - $12.07 $998,666 - $1.87 Million	-154,832 Reduced 74.64%	52,595 $485,000
Q3 2022 Nov 14, 2022	BUY	$7.86 - $12.91 $1.63 Million - $2.68 Million	207,427 New	207,427 $1.79 Million

282

124M

751K

107K

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.21B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

Get notified when there are updates to the investment portfolio of Edgestream Partners, L.P., based on Form 13F filings with the SEC.

Stay updated on Edgestream Partners, L.P. with notifications on news.